TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 2, 2013, Pages 128-137

  Wang, Hui ^a   Wang, Lin ^a   Song, Li ^a   Zhang, Yan Wan ^a   Ye, Jue ^a   Xu, Rui Xia ^a   Shi, Na ^a   Meng, Xian Min ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Contraction function; cTnI; Phosphorylation; TNNI3K

Indexed keywords

ADENOVIRUS VECTOR; SERINE; THREONINE; TROPONIN I; TROPONIN I INTERACTING KINASE; UNCLASSIFIED DRUG; PROTEIN TYROSINE KINASE; TNNI3K PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE SILENCING; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MYOFILAMENT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION; WESTERN BLOTTING; ANIMAL; CHEMISTRY; CYTOLOGY; HEART MUSCLE CELL; HEART VENTRICLE; METABOLISM; MUSCLE FIBRIL; PHOSPHORYLATION; PLASMID;

ANIMALS; HEART VENTRICLES; IMMUNOPRECIPITATION; MYOCYTES, CARDIAC; MYOFIBRILS; PHOSPHORYLATION; PLASMIDS; PROTEIN-TYROSINE KINASES; RATS; TROPONIN I;

EID: 84875660786     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20122515     Document Type: Article

References (35)

1. Zhao Y, Meng XM, Wei YJ, Zhao XW, Liu DQ, Cao HQ, et al. Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J Mol Med 2003; 81: 297-304.
2. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298: 1912-1934, doi: 10.1126/science. 1075762.
3. Feng Y, Cao HQ, Liu Z, Ding JF, Meng XM. Identification of the dual specificity and the functional domains of the cardiac-specific protein kinase TNNI3K. Gen Physiol Biophys 2007; 26: 104-109.
4. Feng Y, Liu DQ, Wang Z, Liu Z, Cao HQ, Wang LY, et al. AOP-1 interacts with cardiac-specific protein kinase TNNI3K and down-regulates its kinase activity. Biochemistry 2007; 72: 1199-1204.
5. Ward DG, Cornes MP, Trayer IP. Structural consequences of cardiac troponin I phosphorylation. J Biol Chem 2002; 277: 41795-41801, doi: 10.1074/jbc.M206744200.
6. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res 2004; 94: 146-158, doi: 10.1161/01.RES.0000110083.17024.60.
7. Sadayappan S, Finley N, Howarth JW, Osinska H, Klevitsky R, Lorenz JN, et al. Role of the acidic N9 region of cardiac troponin I in regulating myocardial function. FASEB J 2008;22: 1246-1257, doi: 10.1096/fj.07-9458com.
8. Solaro RJ, Rarick HM. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofila-ments. Circ Res 1998; 83: 471-480, doi: 10.1161/01.RES. 83.5.471.
9. Solaro RJ, Van Eyk J. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 1996; 28: 217-230,doi: 10.1006/jmcc.1996.0021.
10. Bilchick KC, Duncan JG, Ravi R, Takimoto E, Champion HC, Gao WD, et al. Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function. Am J Physiol Heart Circ Physiol 2007; 292: H318-H325, doi: 10.1152/ajpheart.00283.2006.
11. Layland J, Solaro RJ, Shah AM. Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res 2005; 66: 12-21, doi: 10.1016/j.cardiores. 2004.12.022.
12. Murphy AM. Heart failure, myocardial stunning, and troponin: a key regulator of the cardiac myofilament. Congest Heart Fail 2006; 12: 32-38, doi: 10.1111/j.1527-5299.2006.04320.x.
13. Schluter KD, Schreiber D. Adult ventricular cardiomyocytes: isolation and culture. Methods Mol Biol 2005; 290: 305-314.
14. Hanks SK, Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 1995; 9: 576-596.
15. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 1988; 241: 42-52, doi: 10.1126/science. 3291115.
16. Engel PL, Hinken A, Solaro RJ. Differential effects of phosphorylation of regions of troponin I in modifying cooperative activation of cardiac thin filaments. J Mol Cell Cardiol 2009; 47: 359-364, doi: 10.1016/j.yjmcc.2009. 04.016.
17. Sakthivel S, Finley NL, Rosevear PR, Lorenz JN, Gulick J, Kim S, et al. In vivo and in vitro analysis of cardiac troponin I phosphorylation. J Biol Chem 2005; 280: 703-714.
18. Westfall MV, Borton AR, Albayya FP, Metzger JM. Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants. Circ Res 2002; 91: 525-531, doi: 10.1161/01.RES.0000034710. 46739.C0.
19. VanBuren P, Okada Y. Thin filament remodeling in failing myocardium. Heart Fail Rev 2005; 10: 199-209, doi: 10.1007/s10741-005-5250-8.
20. Hamdani N, de Waard M, Messer AE, Boontje NM, Kooij V, van Dijk S, et al. Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil 2008; 29: 189-201, doi: 10.1007/s10974-008-9160-y.
21. 2+ sensitivity and ATPase activity in the mouse myocardium. J Physiol 2003; 552: 845-857, doi: 10.1113/jphy-siol.2003.045260.
22. 2+ sensitivity. J Mol Cell Cardiol 2002; 34: 469-482, doi: 10.1006/jmcc.2002.1528.
23. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, et al. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 2001; 88: 1059-1065, doi: 10.1161/hh1001.091640.
24. Noland TA Jr., Raynor RL, Kuo JF. Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J Biol Chem 1989; 264: 20778-20785.
25. Seguchi O, Takashima S, Yamazaki S, Asakura M, Asano Y, Shintani Y, et al. A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest 2007; 117: 2812-2824, doi: 10.1172/JCI30804.
26. Haworth RS, Cuello F, Herron TJ, Franzen G, Kentish JC, Gautel M, et al. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofila-ment function. Circ Res 2004; 95: 1091-1099, doi: 10.1161/ 01.RES.0000149299.34793.3c.
27. Murphy AM. Another new kinase targets troponin I. Circ Res 2004; 95: 1043-1045, doi: 10.1161/01.RES.0000150051. 81155.88.
28. You B, Yan G, Zhang Z, Yan L, Li J, Ge Q, et al. Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1. Biochem J 2009; 418: 93-101, doi: 10.1042/BJ20081340.
29. Layland J, Li JM, Shah AM. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 2002; 540: 457-467,doi: 10.1113/jphysiol.2001.014126.
30. 2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes. Am J Physiol Cell Physiol 2009; 296: C47-C58, doi: 10.1152/ajpcell.00012.2008.
31. Buscemi N, Foster DB, Neverova I, Van Eyk JE. P21-activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. Circ Res 2002; 91: 509-516, doi: 10.1161/01.RES. 0000035246.27856.53.
32. Stelzer JE, Patel JR, Walker JW, Moss RL. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res 2007; 101: 503-511, doi: 10.1161/CIRCRESAHA.107.153650.
33. Roman BB, Goldspink PH, Spaite E, Urboniene D, McKinney R, Geenen DL, et al. Inhibition of PKC phosphor-ylation of cTnI improves cardiac performance in vivo. Am J Physiol Heart Circ Physiol 2004; 286: H2089-H2095, doi: 10.1152/ajpheart.00582.2003.
34. Wang XJ, Yang X, Chen JZ, Song XD, Yi Zhen, Wang SX, et al. TNNI3K, a cardiac-specific kinase, promotes cardiac hypertrophy in vivo. Circulation 2006; 114: 2-5, doi: 10.1161/CIRCULATIONAHA.106.643940.
35. Wang L, Wang H, Ye J, Xu RX, Song L, Shi N, et al. Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy. Clin Exp Pharmacol Physiol 2011; 38: 278-284, doi: 10.1111/j.1440-1681.2011.05499.x.